In a Phase 1/2 clinical trial investigational RNA therapy QR-421a showed a benefit in vision. ProQR plans to start final phase trials for USH2A mediated retinitis pigmentosa.
We caught up with Lance Johnson, a podcaster and video editor, living with autosomal dominant retinitis pigmentosa (adRP). Since moving to New York City, Lance has started the See-Through Podcast, championing people from across the disability communi
Podcast about genetic testing for inherited retinal disease and how getting a genetic diagnosis empowers the IRD community. The guests are Kari Branham (genetic counsellor) and Ben Shaberman (Foundation Fighting Blindness).
